Premenstrual syndrome in women of reproductive age Urological and Genital Diseases
Conditions
Interventions
Participants were assigned through 1:1 randomization using a computer-generated randomization list to receive either Agrigenina® or a placebo. Agrigenina® was administered as gastro-resistant capsules
Sponsors
NGN Healthcare—New Generation Nutraceuticals s.r.l.
Eligibility
Sex/Gender
Female
Age
18 Years to 46 Years
Inclusion criteria
Inclusion criteria: 1. Women aged 18–46 years 2. Presence of premenstrual syndrome defined as recurrent somatic, psychological, or behavioral symptoms occurring during the premenstrual and/or menstrual phase in at least four of the previous six menstrual cycles, including the most recent one 3. Regular menstrual cycle 4. Willingness to maintain usual dietary habits and physical activity levels throughout the study period
Exclusion criteria
Exclusion criteria: 1. History of chronic diseases such as coagulopathies, diabetes, cardiovascular or renal disorders 2. Cigarette smoking or alcohol consumption 3. Use of nutritional supplements or hormonal medications during the study period 4. Allergy or hypersensitivity to dietary supplements or study product components 5. Irregular menstruation 6. Pregnancy or breastfeeding 7. History of psychological or psychiatric disorders 8. Stressful events occurring in the three months prior to the beginning of the study that could represent a confounding factor
Countries
Italy
Contacts
Public ContactFortuna Iannuzzo
Outcome results
None listed